JP7685522B2 - 新規アクリジニウム塩およびその製造方法 - Google Patents

新規アクリジニウム塩およびその製造方法 Download PDF

Info

Publication number
JP7685522B2
JP7685522B2 JP2022563761A JP2022563761A JP7685522B2 JP 7685522 B2 JP7685522 B2 JP 7685522B2 JP 2022563761 A JP2022563761 A JP 2022563761A JP 2022563761 A JP2022563761 A JP 2022563761A JP 7685522 B2 JP7685522 B2 JP 7685522B2
Authority
JP
Japan
Prior art keywords
group
alkyloxy
formula
acridinium salt
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022563761A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022107755A1 (https=
JPWO2022107755A5 (https=
Inventor
翔平 馬島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of JPWO2022107755A1 publication Critical patent/JPWO2022107755A1/ja
Publication of JPWO2022107755A5 publication Critical patent/JPWO2022107755A5/ja
Application granted granted Critical
Publication of JP7685522B2 publication Critical patent/JP7685522B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/006Catalysts comprising hydrides, coordination complexes or organic compounds comprising organic radicals, e.g. TEMPO
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235Nitrogen containing compounds
    • B01J31/0244Nitrogen containing compounds with nitrogen contained as ring member in aromatic compounds or moieties, e.g. pyridine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/02Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235Nitrogen containing compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J35/00Catalysts, in general, characterised by their form or physical properties
    • B01J35/30Catalysts, in general, characterised by their form or physical properties characterised by their physical properties
    • B01J35/39Photocatalytic properties
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
JP2022563761A 2020-11-17 2021-11-16 新規アクリジニウム塩およびその製造方法 Active JP7685522B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020191118 2020-11-17
JP2020191118 2020-11-17
PCT/JP2021/042049 WO2022107755A1 (ja) 2020-11-17 2021-11-16 新規アクリジニウム塩およびその製造方法

Publications (3)

Publication Number Publication Date
JPWO2022107755A1 JPWO2022107755A1 (https=) 2022-05-27
JPWO2022107755A5 JPWO2022107755A5 (https=) 2024-09-10
JP7685522B2 true JP7685522B2 (ja) 2025-05-29

Family

ID=81707996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022563761A Active JP7685522B2 (ja) 2020-11-17 2021-11-16 新規アクリジニウム塩およびその製造方法

Country Status (6)

Country Link
US (1) US20230278960A1 (https=)
EP (1) EP4249077A4 (https=)
JP (1) JP7685522B2 (https=)
CN (1) CN116783167A (https=)
AR (1) AR124071A1 (https=)
WO (1) WO2022107755A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250129029A1 (en) * 2021-09-06 2025-04-24 Osaka University Acridine compound
CN116082361B (zh) * 2023-04-11 2023-06-13 和鼎(南京)医药技术有限公司 一种制备玛巴洛沙韦中间体和玛巴洛沙韦的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016196816A1 (en) 2015-06-03 2016-12-08 The University Of North Carolina At Chapel Hill Photoredox-catalyzed direct c-h functionalization of arenes
WO2020176804A1 (en) 2019-02-28 2020-09-03 The University Of North Carolina At Chapel Hill Direct aromatic carbon-oxygen and carbon-hydrogen bond functionalization via organic photoredox catalyst

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2320908T1 (sl) 2008-07-25 2014-05-30 Viiv Healthcare Company Predzdravila dolutegravirja
WO2010011819A1 (en) 2008-07-25 2010-01-28 Smithkline Beecham Corporation Chemical compounds
CA2744019C (en) 2008-12-11 2017-03-14 Shionogi & Co., Ltd. Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
KR101682058B1 (ko) 2008-12-11 2016-12-02 비이브 헬쓰케어 컴퍼니 카르바모일피리돈 hiv 인테그라제 억제제를 위한 제조방법 및 중간체
TWI518084B (zh) 2009-03-26 2016-01-21 鹽野義製藥股份有限公司 哌喃酮與吡啶酮衍生物之製造方法
US20140011995A1 (en) 2010-08-05 2014-01-09 Yukihito Sumino Process for Preparing Compound Having HIV Integrase Inhibitory Activity
WO2014128545A2 (en) 2013-02-19 2014-08-28 Aurobindo Pharma Limited An improved process for the preparation of dolutegravir
EP3022209B1 (en) 2013-07-17 2018-03-07 ratiopharm GmbH Dolutegravir potassium salt
WO2015019310A1 (en) 2013-08-07 2015-02-12 Mylan Laboratories Ltd Process for the preparation of dolute-gravir and intermediates thereof
US9856271B2 (en) 2014-01-21 2018-01-02 Laurus Labs Limited Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
ZA201503540B (en) 2014-05-20 2016-10-26 Cipla Ltd Process for preparing polycyclic carbamoyl pyridone derivatives
WO2016092527A1 (en) 2014-12-12 2016-06-16 Sun Pharmaceutical Industries Limited A process for the preparation of dolutegravir
US10730888B2 (en) 2015-02-06 2020-08-04 Mylan Laboratories Limited Process for the preparation of dolutegravir
BR112017022550B1 (pt) 2015-04-28 2021-02-23 Shionogi & Co., Ltd derivados policíclicos de piridona substituída
AU2016374416A1 (en) 2015-12-15 2018-06-14 Shionogi & Co., Ltd. Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug
JP6924839B2 (ja) * 2017-10-06 2021-08-25 塩野義製薬株式会社 置換された多環性ピリドン誘導体の立体選択的な製造方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016196816A1 (en) 2015-06-03 2016-12-08 The University Of North Carolina At Chapel Hill Photoredox-catalyzed direct c-h functionalization of arenes
WO2020176804A1 (en) 2019-02-28 2020-09-03 The University Of North Carolina At Chapel Hill Direct aromatic carbon-oxygen and carbon-hydrogen bond functionalization via organic photoredox catalyst

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE JOURNAL OF ORGANIC CHEMISTRY,2016年,81,7244-7249

Also Published As

Publication number Publication date
JPWO2022107755A1 (https=) 2022-05-27
CN116783167A (zh) 2023-09-19
US20230278960A1 (en) 2023-09-07
EP4249077A4 (en) 2025-02-12
AR124071A1 (es) 2023-02-08
WO2022107755A1 (ja) 2022-05-27
EP4249077A1 (en) 2023-09-27

Similar Documents

Publication Publication Date Title
KR102714478B1 (ko) 치환된 다환성 피리돈 유도체의 입체 선택적인 제조 방법
CN103154004B (zh) 具有hiv整合酶抑制活性的化合物的制造方法
CN114805330B (zh) Hpk1抑制剂、其制备方法、药物组合物及其应用
JP7685522B2 (ja) 新規アクリジニウム塩およびその製造方法
WO2022198904A1 (zh) 一种kras抑制剂关键中间体及其制备方法
US12612415B2 (en) Stereoselective process for preparing substituted polycyclic pyridone
HK40100797A (zh) 新颖吖啶鎓盐及其制造方法
HK40028700A (en) Method for stereoselectively producing substituted polycyclic pyridone derivative
HK40028700B (en) Method for stereoselectively producing substituted polycyclic pyridone derivative
BR112020006639B1 (pt) Compostos e processo estereosseletivo para a preparação de derivados policíclicos substituídos de piridona
TW201811787A (zh) 2-(6-硝基吡碇-3-基)-9H-二吡碇并[2,3-b;3’,4’-d]吡咯之製備方法
HK1180676A (en) Process for preparing compound having hiv integrase inhibitory activity
HK1229321A1 (en) Process for preparing compound having hiv integrase inhibitory activity
HK1229321B (en) Process for preparing compound having hiv integrase inhibitory activity
HK40005960B (en) Method of producing compounds having hiv integrase inhivitory activity
HK40005960A (en) Method of producing compounds having hiv integrase inhivitory activity
HK1229321A (en) Process for preparing compound having hiv integrase inhibitory activity
HK1180676B (en) Process for preparing compound having hiv integrase inhibitory activity

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240902

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240902

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250422

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250519

R150 Certificate of patent or registration of utility model

Ref document number: 7685522

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150